跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APIXABAN TAD 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
APIXABAN TAD 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
APIXABAN TAD 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Tad Pharma Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 30, 2021
Approval ID
95d53f8e47caae30
Company
Tad Pharma Gmbh
Type
Standard
Approval Details
Approval Id
95d53f8e47caae30
Drug Cima Aemps Name
APIXABAN TAD 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
86418
Holder Company Name
Tad Pharma Gmbh
Marketing Company Name
Krka Farmaceutica S.L.
Holder Company Detail Path
/organization/tad-pharma-gmbh
Authorization Date
2021-11-30
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Tad Pharma Gmbh
Company Detail Path
/organization/tad-pharma-gmbh
Company Information
Pharmaceutical Company Name
TAD Pharma GmbH
Country Name
Germany
City Name
cuxhaven,niedersachsen,country_de
Address
Heinz-Lohmann-Str. 5
Active Ingredients
APIXABAN
5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 30, 2021
Approval ID
95d53f8e47caae30
Type
Standard
Back to CIMA-AEMPS Approvals